McKesson Eyes Option Care Deal With CD&R
McKesson is reportedly considering an acquisition of Option Care, a move that could be announced soon. Option Care's stock rose 21% on the news, reflecting market expectations of a $5 billion deal. McKesson declined to comment on the potential acquisition.
How this was made
The 30-second read
Why it matters
If the deal proceeds, McKesson could expand its specialty pharmacy footprint, while Option Care shareholders may receive a premium.
Market read
The rumored $5 billion deal could reshape the healthcare distribution landscape and move both stocks.
What to watch
Regulatory approval risk and financing terms could delay or derail the transaction.
Background
McKesson, a leading drug distributor, is exploring a takeover of Option Care Health, a specialty pharmacy provider, with private‑equity firm CD&R involved.
Ticker impact
McKesson is reported to be negotiating a potential $5 billion acquisition of Option Care Health.
likely upside as market prices in acquisition premium expectations
First report of a large‑scale M&A talks; $5 B size is material for both mid‑cap participants.
Option Care Health is the target of a rumored $5 billion acquisition by McKesson.
likely upside driven by acquisition premium expectations
Deal rumors are fresh and sizable, creating immediate pricing pressure on the target.
Market effects
Consolidation trend in healthcare distribution could pressure peers.
U.S. healthcare sector may see modest rally on M&A optimism.
Large deal size underscores ongoing consolidation in global pharma supply chains.
Counterpoint
Deal could fall apart, causing a sell‑off in both stocks if negotiations stall.
Key entities
- CompanyMcKesson Corporation
U.S. drug distributor and potential acquirer.
- CompanyOption Care Health
Specialty pharmacy services provider and acquisition target.
- Private EquityClayton, Dubilier & Rice
Financial sponsor involved in the potential transaction.
